• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AI

ALGORAE PHARMACEUTICALS LIMITED - Announcements

0.00% ! 0.6¢
Market Cap $10.96M  !

Algorae Pharmaceuticals Limited is an Australia-based artificial-intelligence (AI)... Algorae Pharmaceuticals Limited is an Australia-based artificial-intelligence (AI) enabled drug discovery and development company. The Company is actively engaged in expanding its therapeutic pipeline using a proprietary artificial intelligence (AI) drug discovery and development platform, known as Algorae Operating System (AlgoraeOS). The AI platform leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. By employing machine learning, deep learning, and neural networks, the AlgoraeOS is focused on uncovering synergistic fixed dose drug combinations that lead to the development of effective treatments for any medical condition. It is also focused on advancing its drug candidates, which include AI-116 for the treatment of neurodegenerative disorders and/or dementia, and AI-168 for cardiovascular disease and NTCELL for Parkinson’s disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



1AI Living Insights Newsletter01/12/16 download Created with Sketch. 522.93KB
1AI Reinstatement to Official QuotationPRICE SENSITIVE30/11/16 download Created with Sketch. 232.05KB
1AI Private PlacementPRICE SENSITIVE30/11/16 download Created with Sketch. 437.34KB
1AI Suspension from Official QuotationPRICE SENSITIVE28/11/16 download Created with Sketch. 331.96KB
1AI Trading HaltPRICE SENSITIVE24/11/16 download Created with Sketch. 497.23KB
1AI Results of Annual General Meeting16/11/16 download Created with Sketch. 95.13KB
1AI Chairman and CEO Presentation to Annual General Meeting16/11/16 download Created with Sketch. 1.12MB
1AI Approval granted for group 2 in Parkinsons trialPRICE SENSITIVE11/11/16 download Created with Sketch. 333.64KB
1AI Appendix 4C Quarterly Cash Flow Report 30 September 2016-LCT.AX PRICE SENSITIVE20/10/16 download Created with Sketch. 623.51KB
1AI Notice of Annual General Meeting/Proxy Form-LCT.AX 17/10/16 download Created with Sketch. 490.44KB
1AI Annual Report to shareholders-LCT.AX 17/10/16 download Created with Sketch. 8.03MB
1AI Group 1 patients successfully treated in Parkinsons trial-LCT.AX PRICE SENSITIVE05/10/16 download Created with Sketch. 334.12KB
1AI 2016 Annual General Meeting and Director Nominations-LCT.AX 20/09/16 download Created with Sketch. 493.77KB
1AI Investor Presentation-LCT.AX 01/09/16 download Created with Sketch. 1.03MB
1AI Appendix 4G-LCT.AX 28/08/16 download Created with Sketch. 371.92KB
1AI Appendix 4G-LCT.AX 25/08/16 download Created with Sketch. 371.92KB
1AI Preliminary Final Report and Financial Statements-LCT.AX PRICE SENSITIVE24/08/16 download Created with Sketch. 1.8MB
1AI LCT's joint venture focuses on US developments-LCT.AX PRICE SENSITIVE22/08/16 download Created with Sketch. 321.01KB
1AI Response to ASX Price Query-LCT.AX PRICE SENSITIVE17/08/16 download Created with Sketch. 504.36KB
1AI Appendix 4C - quarterly-LCT.AX PRICE SENSITIVE28/07/16 download Created with Sketch. 589.86KB
1AI Living Insights Newsletter-LCT.AX 26/07/16 download Created with Sketch. 1.09MB
1AI NTCELL Trial Results to be Presented in Berlin-LCT.AX 23/06/16
1AI NTCELL Trial Results to be Presented in Berlin-LCT.AX 23/06/16 download Created with Sketch. 816.42KB
1AI Response to ASX Price Query-LCT.AX PRICE SENSITIVE22/06/16 download Created with Sketch. 249.63KB
1AI Appendix 3B-LCT.AX 08/06/16 download Created with Sketch. 319.95KB
1AI NTCELL demonstrates continued reversal of Parkinsons-LCT.AX PRICE SENSITIVE07/06/16 download Created with Sketch. 390.84KB
1AI Appendix 4G-LCT.AX 16/05/16 download Created with Sketch. 586.82KB
1AI Appendix 3B-LCT.AX 10/05/16 download Created with Sketch. 439.72KB
1AI Cleansing Statement-LCT.AX 21/04/16 download Created with Sketch. 146.47KB
1AI Appendix 3B-LCT.AX 21/04/16 download Created with Sketch. 536.29KB
1AI LCT successfully completes funding round-LCT.AX 21/04/16 download Created with Sketch. 315.71KB
1AI Appendix 4C - quarterly-LCT.AX PRICE SENSITIVE14/04/16 download Created with Sketch. 572.24KB
1AI Change in substantial holding-LCT.AX 08/04/16 download Created with Sketch. 176.88KB
1AI Ceasing to be a substantial holder-LCT.AX 07/04/16 download Created with Sketch. 133.38KB
1AI Appendix 3B-LCT.AX 06/04/16 download Created with Sketch. 508.24KB
1AI LCT share purchase plan raises $0.5m-LCT.AX 04/04/16 download Created with Sketch. 314.98KB
1AI LCT starts Phase IIb clinical trial of NTCELLPRICE SENSITIVE24/03/16 download Created with Sketch. 332.92KB
1AI Extension of SPP Closing Date to 29 March 201609/03/16 download Created with Sketch. 230.44KB
1AI Half Yearly Report and AccountsPRICE SENSITIVE26/02/16 download Created with Sketch. 776.28KB
1AI Dispatch of Share Purchase Plan Offer Documents23/02/16 download Created with Sketch. 584.27KB
1AI Becoming a substantial holder19/02/16 download Created with Sketch. 151.06KB
1AI Cleansing Statement18/02/16 download Created with Sketch. 193.32KB
1AI Appendix 3B18/02/16 download Created with Sketch. 200.93KB
1AI LCT completes $2.8m private placement and announces SPPPRICE SENSITIVE17/02/16 download Created with Sketch. 81.11KB
1AI LCT receives ethics approval for Phase IIb Parkinsons trialPRICE SENSITIVE03/02/16 download Created with Sketch. 76.41KB
1AI NTCELL reverses the progression of Parkinsons diseasePRICE SENSITIVE27/01/16 download Created with Sketch. 87.35KB
1AI Commentary on Appendix 4C - 31 December 2015PRICE SENSITIVE12/01/16 download Created with Sketch. 72.11KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE12/01/16 download Created with Sketch. 97.39KB
1AI Change of Company Secretary, Registered Office Address05/01/16 download Created with Sketch. 35.84KB
1AI LCT complies with ASIC infringement noticePRICE SENSITIVE18/12/15 download Created with Sketch. 51.91KB
1AI LCT secures supply of NTCELLPRICE SENSITIVE02/12/15 download Created with Sketch. 48.3KB
1AI Special CEO Update18/11/15 download Created with Sketch. 284.96KB
1AI Update on clinical trials of encapsulated pig isletsPRICE SENSITIVE16/11/15 download Created with Sketch. 3.18MB
1AI Results of Annual General Meeting13/11/15 download Created with Sketch. 50.86KB
1AI CEO Presentation to Annual General Meeting12/11/15 download Created with Sketch. 1.12MB
1AI Minister authorises Phase IIb Parkinson's studyPRICE SENSITIVE12/11/15 download Created with Sketch. 50.17KB
1AI FY15 Annual Report - Rectification to Auditor's Report11/11/15 download Created with Sketch. 151.16KB
1AI NTCELL - Parkinson's trial 42 week resultPRICE SENSITIVE27/10/15 download Created with Sketch. 49.06KB
1AI Commentary on Appendix 4C - 30 September 201514/10/15 download Created with Sketch. 48.78KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE14/10/15 download Created with Sketch. 51.13KB
1AI Annual Report to shareholders09/10/15 download Created with Sketch. 3.03MB
1AI Notice of Annual General Meeting/Proxy Form09/10/15 download Created with Sketch. 498.46KB
1AI Change of Director's Interest Notice15/09/15 download Created with Sketch. 22.04KB
1AI Change of Director's Interest Notice03/09/15 download Created with Sketch. 22.01KB
1AI LCT to receive Callaghan Innovation Growth GrantPRICE SENSITIVE28/08/15 download Created with Sketch. 49.23KB
1AI Preliminary Final Report 30 June 201519/08/15 download Created with Sketch. 49.04KB
1AI Appendix 4E and Financial Statements YE 30 June 2015PRICE SENSITIVE19/08/15 download Created with Sketch. 670.18KB
1AI LCT planning to resume control of NTCELL manufacturePRICE SENSITIVE18/08/15 download Created with Sketch. 48.75KB
1AI Living Insights Newsletter05/08/15 download Created with Sketch. 1.11MB
1AI Response to ASX aware letterPRICE SENSITIVE29/07/15 download Created with Sketch. 385.73KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE27/07/15 download Created with Sketch. 493.17KB
1AI Proposed grant of options to Directors14/07/15 download Created with Sketch. 272.63KB
1AI Update to DIABECELL development strategyPRICE SENSITIVE26/06/15 download Created with Sketch. 49.36KB
1AI LCT hosts conference call on Clinical Study in Parkinson's18/06/15 download Created with Sketch. 26.69KB
1AI Parkinson's Congress NTCELL Poster Presentation16/06/15 download Created with Sketch. 1.08MB
1AI NTCELL Clinical Study - Investor Conf. Call Time Correction15/06/15 download Created with Sketch. 17.41KB
1AI NTCELL Clinical Study in Parkinson's Meets EndpointsPRICE SENSITIVE15/06/15 download Created with Sketch. 31.09KB
1AI Trading HaltPRICE SENSITIVE12/06/15 download Created with Sketch. 49.25KB
1AI CEO Remuneration05/06/15 download Created with Sketch. 47.92KB
1AI LCT JV adopts new strategy for DIABECELLPRICE SENSITIVE05/03/15 download Created with Sketch. 39.07KB
1AI Professor Elliott steps down from executive position24/02/15 download Created with Sketch. 270.39KB
1AI Half Yearly Report and AccountsPRICE SENSITIVE18/02/15 download Created with Sketch. 338.53KB
1AI Appendix 3B02/02/15 download Created with Sketch. 50.5KB
1AI Appendix 4C - quarterlyPRICE SENSITIVE28/01/15 download Created with Sketch. 100.74KB
1AI Change of Registered Office Address19/01/15 download Created with Sketch. 21.11KB
1AI LCT completes patient implants in Parkinson's trialPRICE SENSITIVE15/12/14 download Created with Sketch. 21.96KB
1AI Amended Appendix 3B09/12/14 download Created with Sketch. 106.7KB
1AI Share Purchase Plan-Cleansing Notice08/12/14 download Created with Sketch. 13.82KB
1AI Appendix 3B08/12/14 download Created with Sketch. 106.71KB
1AI LCT share purchase plan raises $1.08m04/12/14 download Created with Sketch. 21.49KB
1AI Results of Annual General Meeting18/11/14 download Created with Sketch. 51.14KB
1AI CEO Presentation to 2014 AGM18/11/14 download Created with Sketch. 675.37KB
1AI Chairman's Presentation to 2014 AGM18/11/14 download Created with Sketch. 324.81KB
1AI Chairman's Address to 2014 AGM18/11/14 download Created with Sketch. 23.79KB
1AI Recruitment of all patients in Parkinson's trial completed03/11/14 download Created with Sketch. 272.88KB
1AI Appendix 4C 30 Sep 2014PRICE SENSITIVE28/10/14 download Created with Sketch. 96.33KB
1AI LCT Share Purchase Plan extended to 28 November 201428/10/14 download Created with Sketch. 48.05KB
1AI Notice of Annual General Meeting/Proxy Form17/10/14 download Created with Sketch. 345.2KB
1AI Annual Report to shareholders17/10/14 download Created with Sketch. 1.27MB
1AI Share Purchase Plan Offer Terms and Conditions15/10/14 download Created with Sketch. 471.17KB
1AI Living Insights Newsletter
01/12/16 download Created with Sketch. 522.93KB
1AI Reinstatement to Official Quotation
30/11/16PRICE SENSITIVE download Created with Sketch. 232.05KB
1AI Private Placement
30/11/16PRICE SENSITIVE download Created with Sketch. 437.34KB
1AI Suspension from Official Quotation
28/11/16PRICE SENSITIVE download Created with Sketch. 331.96KB
1AI Trading Halt
24/11/16PRICE SENSITIVE download Created with Sketch. 497.23KB
1AI Results of Annual General Meeting
16/11/16 download Created with Sketch. 95.13KB
1AI Chairman and CEO Presentation to Annual General Meeting
16/11/16 download Created with Sketch. 1.12MB
1AI Approval granted for group 2 in Parkinsons trial
11/11/16PRICE SENSITIVE download Created with Sketch. 333.64KB
1AI Appendix 4C Quarterly Cash Flow Report 30 September 2016-LCT.AX
20/10/16PRICE SENSITIVE download Created with Sketch. 623.51KB
1AI Notice of Annual General Meeting/Proxy Form-LCT.AX
17/10/16 download Created with Sketch. 490.44KB
1AI Annual Report to shareholders-LCT.AX
17/10/16 download Created with Sketch. 8.03MB
1AI Group 1 patients successfully treated in Parkinsons trial-LCT.AX
05/10/16PRICE SENSITIVE download Created with Sketch. 334.12KB
1AI 2016 Annual General Meeting and Director Nominations-LCT.AX
20/09/16 download Created with Sketch. 493.77KB
1AI Investor Presentation-LCT.AX
01/09/16 download Created with Sketch. 1.03MB
1AI Appendix 4G-LCT.AX
28/08/16 download Created with Sketch. 371.92KB
1AI Appendix 4G-LCT.AX
25/08/16 download Created with Sketch. 371.92KB
1AI Preliminary Final Report and Financial Statements-LCT.AX
24/08/16PRICE SENSITIVE download Created with Sketch. 1.8MB
1AI LCT's joint venture focuses on US developments-LCT.AX
22/08/16PRICE SENSITIVE download Created with Sketch. 321.01KB
1AI Response to ASX Price Query-LCT.AX
17/08/16PRICE SENSITIVE download Created with Sketch. 504.36KB
1AI Appendix 4C - quarterly-LCT.AX
28/07/16PRICE SENSITIVE download Created with Sketch. 589.86KB
1AI Living Insights Newsletter-LCT.AX
26/07/16 download Created with Sketch. 1.09MB
1AI NTCELL Trial Results to be Presented in Berlin-LCT.AX
23/06/16
1AI NTCELL Trial Results to be Presented in Berlin-LCT.AX
23/06/16 download Created with Sketch. 816.42KB
1AI Response to ASX Price Query-LCT.AX
22/06/16PRICE SENSITIVE download Created with Sketch. 249.63KB
1AI Appendix 3B-LCT.AX
08/06/16 download Created with Sketch. 319.95KB
1AI NTCELL demonstrates continued reversal of Parkinsons-LCT.AX
07/06/16PRICE SENSITIVE download Created with Sketch. 390.84KB
1AI Appendix 4G-LCT.AX
16/05/16 download Created with Sketch. 586.82KB
1AI Appendix 3B-LCT.AX
10/05/16 download Created with Sketch. 439.72KB
1AI Cleansing Statement-LCT.AX
21/04/16 download Created with Sketch. 146.47KB
1AI Appendix 3B-LCT.AX
21/04/16 download Created with Sketch. 536.29KB
1AI LCT successfully completes funding round-LCT.AX
21/04/16 download Created with Sketch. 315.71KB
1AI Appendix 4C - quarterly-LCT.AX
14/04/16PRICE SENSITIVE download Created with Sketch. 572.24KB
1AI Change in substantial holding-LCT.AX
08/04/16 download Created with Sketch. 176.88KB
1AI Ceasing to be a substantial holder-LCT.AX
07/04/16 download Created with Sketch. 133.38KB
1AI Appendix 3B-LCT.AX
06/04/16 download Created with Sketch. 508.24KB
1AI LCT share purchase plan raises $0.5m-LCT.AX
04/04/16 download Created with Sketch. 314.98KB
1AI LCT starts Phase IIb clinical trial of NTCELL
24/03/16PRICE SENSITIVE download Created with Sketch. 332.92KB
1AI Extension of SPP Closing Date to 29 March 2016
09/03/16 download Created with Sketch. 230.44KB
1AI Half Yearly Report and Accounts
26/02/16PRICE SENSITIVE download Created with Sketch. 776.28KB
1AI Dispatch of Share Purchase Plan Offer Documents
23/02/16 download Created with Sketch. 584.27KB
1AI Becoming a substantial holder
19/02/16 download Created with Sketch. 151.06KB
1AI Cleansing Statement
18/02/16 download Created with Sketch. 193.32KB
1AI Appendix 3B
18/02/16 download Created with Sketch. 200.93KB
1AI LCT completes $2.8m private placement and announces SPP
17/02/16PRICE SENSITIVE download Created with Sketch. 81.11KB
1AI LCT receives ethics approval for Phase IIb Parkinsons trial
03/02/16PRICE SENSITIVE download Created with Sketch. 76.41KB
1AI NTCELL reverses the progression of Parkinsons disease
27/01/16PRICE SENSITIVE download Created with Sketch. 87.35KB
1AI Commentary on Appendix 4C - 31 December 2015
12/01/16PRICE SENSITIVE download Created with Sketch. 72.11KB
1AI Appendix 4C - quarterly
12/01/16PRICE SENSITIVE download Created with Sketch. 97.39KB
1AI Change of Company Secretary, Registered Office Address
05/01/16 download Created with Sketch. 35.84KB
1AI LCT complies with ASIC infringement notice
18/12/15PRICE SENSITIVE download Created with Sketch. 51.91KB
1AI LCT secures supply of NTCELL
02/12/15PRICE SENSITIVE download Created with Sketch. 48.3KB
1AI Special CEO Update
18/11/15 download Created with Sketch. 284.96KB
1AI Update on clinical trials of encapsulated pig islets
16/11/15PRICE SENSITIVE download Created with Sketch. 3.18MB
1AI Results of Annual General Meeting
13/11/15 download Created with Sketch. 50.86KB
1AI CEO Presentation to Annual General Meeting
12/11/15 download Created with Sketch. 1.12MB
1AI Minister authorises Phase IIb Parkinson's study
12/11/15PRICE SENSITIVE download Created with Sketch. 50.17KB
1AI FY15 Annual Report - Rectification to Auditor's Report
11/11/15 download Created with Sketch. 151.16KB
1AI NTCELL - Parkinson's trial 42 week result
27/10/15PRICE SENSITIVE download Created with Sketch. 49.06KB
1AI Commentary on Appendix 4C - 30 September 2015
14/10/15 download Created with Sketch. 48.78KB
1AI Appendix 4C - quarterly
14/10/15PRICE SENSITIVE download Created with Sketch. 51.13KB
1AI Annual Report to shareholders
09/10/15 download Created with Sketch. 3.03MB
1AI Notice of Annual General Meeting/Proxy Form
09/10/15 download Created with Sketch. 498.46KB
1AI Change of Director's Interest Notice
15/09/15 download Created with Sketch. 22.04KB
1AI Change of Director's Interest Notice
03/09/15 download Created with Sketch. 22.01KB
1AI LCT to receive Callaghan Innovation Growth Grant
28/08/15PRICE SENSITIVE download Created with Sketch. 49.23KB
1AI Preliminary Final Report 30 June 2015
19/08/15 download Created with Sketch. 49.04KB
1AI Appendix 4E and Financial Statements YE 30 June 2015
19/08/15PRICE SENSITIVE download Created with Sketch. 670.18KB
1AI LCT planning to resume control of NTCELL manufacture
18/08/15PRICE SENSITIVE download Created with Sketch. 48.75KB
1AI Living Insights Newsletter
05/08/15 download Created with Sketch. 1.11MB
1AI Response to ASX aware letter
29/07/15PRICE SENSITIVE download Created with Sketch. 385.73KB
1AI Appendix 4C - quarterly
27/07/15PRICE SENSITIVE download Created with Sketch. 493.17KB
1AI Proposed grant of options to Directors
14/07/15 download Created with Sketch. 272.63KB
1AI Update to DIABECELL development strategy
26/06/15PRICE SENSITIVE download Created with Sketch. 49.36KB
1AI LCT hosts conference call on Clinical Study in Parkinson's
18/06/15 download Created with Sketch. 26.69KB
1AI Parkinson's Congress NTCELL Poster Presentation
16/06/15 download Created with Sketch. 1.08MB
1AI NTCELL Clinical Study - Investor Conf. Call Time Correction
15/06/15 download Created with Sketch. 17.41KB
1AI NTCELL Clinical Study in Parkinson's Meets Endpoints
15/06/15PRICE SENSITIVE download Created with Sketch. 31.09KB
1AI Trading Halt
12/06/15PRICE SENSITIVE download Created with Sketch. 49.25KB
1AI CEO Remuneration
05/06/15 download Created with Sketch. 47.92KB
1AI LCT JV adopts new strategy for DIABECELL
05/03/15PRICE SENSITIVE download Created with Sketch. 39.07KB
1AI Professor Elliott steps down from executive position
24/02/15 download Created with Sketch. 270.39KB
1AI Half Yearly Report and Accounts
18/02/15PRICE SENSITIVE download Created with Sketch. 338.53KB
1AI Appendix 3B
02/02/15 download Created with Sketch. 50.5KB
1AI Appendix 4C - quarterly
28/01/15PRICE SENSITIVE download Created with Sketch. 100.74KB
1AI Change of Registered Office Address
19/01/15 download Created with Sketch. 21.11KB
1AI LCT completes patient implants in Parkinson's trial
15/12/14PRICE SENSITIVE download Created with Sketch. 21.96KB
1AI Amended Appendix 3B
09/12/14 download Created with Sketch. 106.7KB
1AI Share Purchase Plan-Cleansing Notice
08/12/14 download Created with Sketch. 13.82KB
1AI Appendix 3B
08/12/14 download Created with Sketch. 106.71KB
1AI LCT share purchase plan raises $1.08m
04/12/14 download Created with Sketch. 21.49KB
1AI Results of Annual General Meeting
18/11/14 download Created with Sketch. 51.14KB
1AI CEO Presentation to 2014 AGM
18/11/14 download Created with Sketch. 675.37KB
1AI Chairman's Presentation to 2014 AGM
18/11/14 download Created with Sketch. 324.81KB
1AI Chairman's Address to 2014 AGM
18/11/14 download Created with Sketch. 23.79KB
1AI Recruitment of all patients in Parkinson's trial completed
03/11/14 download Created with Sketch. 272.88KB
1AI Appendix 4C 30 Sep 2014
28/10/14PRICE SENSITIVE download Created with Sketch. 96.33KB
1AI LCT Share Purchase Plan extended to 28 November 2014
28/10/14 download Created with Sketch. 48.05KB
1AI Notice of Annual General Meeting/Proxy Form
17/10/14 download Created with Sketch. 345.2KB
1AI Annual Report to shareholders
17/10/14 download Created with Sketch. 1.27MB
1AI Share Purchase Plan Offer Terms and Conditions
15/10/14 download Created with Sketch. 471.17KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $10.96M
Open High Low Value Volume
0.6¢ 0.7¢ 0.6¢ $52.58K 8.060M

Buyers (Bids)

No. Vol. Price($)
10 4116515 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 837702 2
View Market Depth
Last trade - 13.59pm 11/08/2025 (20 minute delay) ?
Last
0.6¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
0.6¢ 0.7¢ 0.6¢ 2615125
Last updated 13.33pm 11/08/2025 ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.